1 / 3
google
Article details
- Package size
- 56
- Selling units
- 56
- Measure
- Kapsel(n)
- Galenic form
- Kapseln
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
niraparibum
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
niraparibi tosilas monohydricus
|
- | Substance | WIZUS |
|
E 133
|
- | Substance | FIMDK |
|
E 127
|
- | Substance | FIMDK |
|
E 102
|
- | Substance | FIMDK |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 66763
- Drug name
- Zejula, Kapseln
- Galenic form
- KAHA
- ATC Code
- L01XK02
- Authorization status
- Revoked/Withdrawn
- Dispensing category
- A
- First authorization
- 03/10/2018
- Authorization expiration date
- 02/12/2025
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- ZEJULA caps 100 mg 56 pce
- Description (DE)
- ZEJULA Kaps 100 mg 56 Stk
- Market launch
- 03/10/2018
- Market withdrawal
- 17/08/2023
- Narcotic (BTM)
- No
Other package sizes (2)
ZEJULA caps 100 mg 84 pce
84 KAP
GTIN: 7680667630029
None
28 KAP
GTIN: None